DIAZEPAM ORAL

DIAZEPAM ORAL was reported 90060 times

DIAZEPAM ORAL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 RHESUS INCOMPATIBILITY 68 0.5620
1 TOTAL LUNG CAPACITY INCREASED 108 0.3971
2 CONGENITAL NYSTAGMUS 79 0.3726
3 VISCERAL CONGESTION 139 0.2720
4 MYOGLOBIN URINE PRESENT 64 0.2602
5 VITAL CAPACITY DECREASED 104 0.2321
6 SUBSTANCE USE DISORDER 687 0.2154
7 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 110 0.2103
8 REVERSIBLE AIRWAYS OBSTRUCTION 104 0.2047
9 STIFF PERSON SYNDROME 62 0.1787
10 BRADYPNOEA 383 0.1418
11 EXPOSURE VIA FATHER 185 0.1418
12 SPUTUM CULTURE POSITIVE 111 0.1367
13 MULTIPLE DRUG OVERDOSE ACCIDENTAL 61 0.1335
14 MULTIPLE DRUG THERAPY 96 0.1273
15 VICTIM OF CHEMICAL SUBMISSION 82 0.1222
16 VICTIM OF CRIME 148 0.1196
17 DRUG USE DISORDER 957 0.1137
18 MIOSIS 826 0.1028
19 POISONING DELIBERATE 934 0.0984
20 ACCIDENTAL DEATH 178 0.0957
21 COMA SCALE ABNORMAL 277 0.0955
22 AGORAPHOBIA 128 0.0935
23 SEDATION COMPLICATION 237 0.0928
24 POISONING 1084 0.0862
25 COGWHEEL RIGIDITY 90 0.0857
26 BRONCHIAL SECRETION RETENTION 108 0.0848
27 MULTIPLE DRUG OVERDOSE 409 0.0823
28 SUBSTANCE ABUSE 667 0.0819
29 RESPIRATORY DEPRESSION 936 0.0763
30 DRUG ABUSE 6198 0.0744
31 HYPOMANIA 265 0.0720
32 PSYCHOGENIC SEIZURE 67 0.0717
33 DROWNING 68 0.0672
34 GASTRIC PH DECREASED 68 0.0663
35 ALCOHOL POISONING 177 0.0660
36 ALCOHOL INTERACTION 121 0.0622
37 NEUROLEPTIC MALIGNANT SYNDROME 738 0.0622
38 DRUG WITHDRAWAL CONVULSIONS 109 0.0612
39 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 62 0.0584
40 JAUNDICE CHOLESTATIC 200 0.0566
41 ACCIDENTAL POISONING 77 0.0561
42 MULTIPLE DRUG OVERDOSE INTENTIONAL 180 0.0559
43 EXPOSURE VIA INGESTION 140 0.0554
44 TOXICITY TO VARIOUS AGENTS 9224 0.0546
45 HYPERPARATHYROIDISM SECONDARY 137 0.0546
46 SCHIZOPHRENIA 647 0.0532
47 RESPIRATORY ARREST 1399 0.0507
48 DEREALISATION 107 0.0497
49 NYSTAGMUS 260 0.0489
50 PSYCHOTIC SYMPTOM 101 0.0489
51 H1N1 INFLUENZA 68 0.0484
52 REBOUND ACID HYPERSECRETION 146 0.0482
53 NEPHROGENIC ANAEMIA 223 0.0481
54 ASPHYXIA 392 0.0480
55 COMA 2271 0.0476
56 SMALL FOR DATES BABY 232 0.0467
57 COMPLETED SUICIDE 3880 0.0465
58 LOGORRHOEA 156 0.0442
59 DRUG TOXICITY 593 0.0435
60 SEROTONIN SYNDROME 800 0.0416
61 ANTIPSYCHOTIC DRUG LEVEL INCREASED 117 0.0415
62 SOPOR 545 0.0411
63 ARTERIOSCLEROSIS CORONARY ARTERY 272 0.0410
64 ALCOHOL ABUSE 109 0.0407
65 ANXIETY DISORDER 136 0.0407
66 PERSONALITY DISORDER 106 0.0404
67 TEARFULNESS 173 0.0402
68 ELECTROENCEPHALOGRAM ABNORMAL 127 0.0402
69 RESPIRATORY ACIDOSIS 158 0.0402
70 HALLUCINATIONS, MIXED 168 0.0399
71 STATUS EPILEPTICUS 445 0.0394
72 POTENTIATING DRUG INTERACTION 132 0.0393
73 DISINHIBITION 63 0.0391
74 DEPRESSED LEVEL OF CONSCIOUSNESS 1527 0.0386
75 MYDRIASIS 495 0.0385
76 HYPOVENTILATION 124 0.0380
77 MULTIPLE-DRUG RESISTANCE 117 0.0377
78 STUPOR 121 0.0376
79 SCHIZOAFFECTIVE DISORDER 66 0.0370
80 BRADYPHRENIA 241 0.0369
81 INTENTIONAL OVERDOSE 2362 0.0368
82 SALIVARY HYPERSECRETION 365 0.0364
83 STRABISMUS 107 0.0364
84 AUTONOMIC NERVOUS SYSTEM IMBALANCE 106 0.0363
85 ALTERED STATE OF CONSCIOUSNESS 767 0.0354
86 SUICIDAL BEHAVIOUR 147 0.0353
87 PERSECUTORY DELUSION 87 0.0349
88 SUICIDE ATTEMPT 2110 0.0348
89 SNORING 131 0.0346
90 SEDATION 895 0.0341
91 PNEUMONIA ASPIRATION 836 0.0334
92 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 86 0.0328
93 CARDIO-RESPIRATORY ARREST 1367 0.0327
94 CREATININE RENAL CLEARANCE DECREASED 129 0.0322
95 CATATONIA 168 0.0320
96 INTENTIONAL SELF-INJURY 643 0.0318
97 ACUTE PSYCHOSIS 78 0.0315
98 RHINITIS ALLERGIC 140 0.0314
99 NEUROLOGICAL DECOMPENSATION 72 0.0311
100 BEHAVIOUR DISORDER 167 0.0308
101 PSYCHOTIC DISORDER 910 0.0308
102 PHYSICAL ASSAULT 64 0.0306
103 CLONUS 83 0.0303
104 HYPOTHERMIA 304 0.0300
105 MUSCLE RIGIDITY 354 0.0296
106 RESPIRATORY RATE DECREASED 92 0.0293
107 PSYCHOMOTOR RETARDATION 81 0.0288
108 SELF-INJURIOUS IDEATION 119 0.0283
109 SELF INJURIOUS BEHAVIOUR 86 0.0282
110 BRAIN OEDEMA 356 0.0282
111 ASPIRATION 306 0.0279
112 PSYCHOMOTOR SKILLS IMPAIRED 73 0.0278
113 DISSOCIATION 213 0.0278
114 PARADOXICAL DRUG REACTION 102 0.0277
115 DROOLING 191 0.0276
116 LONG QT SYNDROME 66 0.0275
117 CLUMSINESS 75 0.0275
118 AGGRESSION 1373 0.0274
119 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 169 0.0273
120 HYPERREFLEXIA 95 0.0272
121 FEELING OF DESPAIR 127 0.0272
122 PULMONARY CONGESTION 358 0.0271
123 AGITATION 1970 0.0268
124 TOXIC ENCEPHALOPATHY 135 0.0266
125 EOSINOPHIL COUNT DECREASED 63 0.0264
126 BRADYKINESIA 155 0.0262
127 DIABETES INSIPIDUS 63 0.0261
128 SARCOIDOSIS 123 0.0259
129 SINUS TACHYCARDIA 367 0.0258
130 DELUSION 398 0.0256
131 AKATHISIA 346 0.0253
132 DRUG DIVERSION 156 0.0252
133 SELF-MEDICATION 103 0.0250
134 PARKINSONISM 244 0.0250
135 LEFT VENTRICULAR HYPERTROPHY 107 0.0250
136 POSTURE ABNORMAL 81 0.0249
137 HYPERTHERMIA 188 0.0246
138 DRUG ABUSER 151 0.0245
139 DRUG SCREEN POSITIVE 194 0.0245
140 DRUG INTERACTION 3886 0.0245
141 AORTIC ARTERIOSCLEROSIS 63 0.0245
142 SUDDEN DEATH 256 0.0242
143 RESTLESSNESS 883 0.0241
144 DYSARTHRIA 902 0.0239
145 ATAXIA 281 0.0237
146 NASAL POLYPS 114 0.0231
147 DYSAESTHESIA 70 0.0228
148 ACCIDENTAL OVERDOSE 834 0.0228
149 PARANOIA 388 0.0225
150 ALCOHOL USE 83 0.0225
151 WITHDRAWAL SYNDROME 941 0.0224
152 TROPONIN INCREASED 170 0.0223
153 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 114 0.0222
154 HYPERACUSIS 82 0.0220
155 CARDIAC ARREST 1814 0.0219
156 AMYLASE INCREASED 81 0.0219
157 GENERALISED TONIC-CLONIC SEIZURE 360 0.0217
158 DELIRIUM 753 0.0217
159 SUICIDAL IDEATION 1939 0.0212
160 SUSPECTED SUICIDE 99 0.0211
161 CARDIAC MURMUR 182 0.0210
162 HALLUCINATION, AUDITORY 332 0.0209
163 FEELING OF BODY TEMPERATURE CHANGE 122 0.0208
164 DYSTONIA 403 0.0208
165 HYPOTONIA 206 0.0206
166 SOCIAL AVOIDANT BEHAVIOUR 119 0.0205
167 DRUG LEVEL ABOVE THERAPEUTIC 94 0.0205
168 THROMBOCYTOSIS 75 0.0204
169 ELECTROCARDIOGRAM QT PROLONGED 730 0.0203
170 PARTIAL SEIZURES 106 0.0202
171 DEPRESSIVE SYMPTOM 71 0.0201
172 THERAPEUTIC AGENT TOXICITY 67 0.0201
173 POST-TRAUMATIC STRESS DISORDER 134 0.0200
174 UNRESPONSIVE TO STIMULI 516 0.0200
175 MUSCLE CONTRACTIONS INVOLUNTARY 70 0.0199
176 BRONCHOPNEUMONIA 68 0.0198
177 INTENTIONAL DRUG MISUSE 413 0.0197
178 END STAGE RENAL DISEASE 359 0.0197
179 INCONTINENCE 208 0.0197
180 CARDIOMEGALY 242 0.0197
181 HYPERTONIA 112 0.0195
182 CHRONIC KIDNEY DISEASE 1482 0.0195
183 OBSTRUCTIVE AIRWAYS DISORDER 214 0.0192
184 TOXIC EPIDERMAL NECROLYSIS 291 0.0191
185 BRONCHIECTASIS 129 0.0191
186 HEPATIC NECROSIS 72 0.0191
187 HEPATIC STEATOSIS 354 0.0190
188 PSYCHOMOTOR HYPERACTIVITY 312 0.0188
189 CYANOSIS 295 0.0187
190 SENSORY LOSS 151 0.0187
191 NEUTROPHIL COUNT INCREASED 192 0.0187
192 RENAL FUNCTION TEST ABNORMAL 87 0.0187
193 CARDIOPULMONARY FAILURE 73 0.0187
194 MYOCLONUS 221 0.0185
195 INTERVERTEBRAL DISC DISORDER 79 0.0185
196 HOMICIDAL IDEATION 75 0.0185
197 PANIC ATTACK 674 0.0185
198 HYPOPNOEA 64 0.0184
199 PETIT MAL EPILEPSY 94 0.0184
200 TENSION 112 0.0184
201 DRUG LEVEL INCREASED 304 0.0183
202 PANIC DISORDER 71 0.0183
203 CEREBRAL ATROPHY 73 0.0183
204 COMMUNICATION DISORDER 70 0.0183
205 ACIDOSIS 139 0.0182
206 MANIA 299 0.0182
207 SOMNOLENCE 3636 0.0180
208 SINUS BRADYCARDIA 174 0.0180
209 HAEMODYNAMIC INSTABILITY 137 0.0180
210 MONOPLEGIA 78 0.0179
211 COORDINATION ABNORMAL 250 0.0179
212 HYPERNATRAEMIA 89 0.0178
213 DISORIENTATION 707 0.0178
214 MULTIPLE ALLERGIES 139 0.0177
215 PRIAPISM 61 0.0177
216 BRAIN INJURY 177 0.0176
217 INCOHERENT 114 0.0176
218 NIGHTMARE 607 0.0175
219 EOSINOPHIL COUNT INCREASED 146 0.0175
220 PANIC REACTION 126 0.0174
221 BUNDLE BRANCH BLOCK RIGHT 80 0.0174
222 HYPERAMMONAEMIA 87 0.0174
223 TACHYCARDIA 1545 0.0174
224 RHABDOMYOLYSIS 725 0.0174
225 RESTLESS LEGS SYNDROME 316 0.0174
226 APNOEA 135 0.0173
227 URINARY RETENTION 577 0.0173
228 LEFT VENTRICULAR DYSFUNCTION 115 0.0172
229 DEVELOPMENTAL DELAY 154 0.0171
230 DRUG LEVEL BELOW THERAPEUTIC 94 0.0170
231 ILEUS PARALYTIC 76 0.0170
232 PERSONALITY CHANGE 158 0.0170
233 BLOOD CREATINE PHOSPHOKINASE INCREASED 487 0.0169
234 ABDOMINAL TENDERNESS 84 0.0169
235 HYPERVENTILATION 98 0.0169
236 MUSCLE SPASTICITY 206 0.0167
237 SOMNAMBULISM 110 0.0167
238 PRE-EXISTING CONDITION IMPROVED 104 0.0166
239 UPPER-AIRWAY COUGH SYNDROME 136 0.0165
240 DISTURBANCE IN ATTENTION 889 0.0165
241 PULMONARY MASS 244 0.0164
242 MENTAL IMPAIRMENT 397 0.0164
243 DECREASED INTEREST 96 0.0163
244 SPINAL OSTEOARTHRITIS 143 0.0163
245 BLOOD CALCIUM DECREASED 183 0.0163
246 IMPULSIVE BEHAVIOUR 61 0.0162
247 SEIZURE 1876 0.0162
248 PSYCHIATRIC SYMPTOM 119 0.0161
249 PREMATURE LABOUR 91 0.0161
250 GASTROINTESTINAL MOTILITY DISORDER 86 0.0161
251 FAECALOMA 88 0.0160
252 FEELING DRUNK 119 0.0160
253 DYSKINESIA 648 0.0159
254 ARTERIOSCLEROSIS 150 0.0159
255 MUSCLE DISORDER 129 0.0159
256 GRAND MAL CONVULSION 147 0.0159
257 TRISMUS 82 0.0159
258 SKIN ABRASION 75 0.0159
259 ENCEPHALOPATHY 389 0.0158
260 ABNORMAL BEHAVIOUR 625 0.0158
261 PULMONARY OEDEMA 696 0.0155
262 INTENTIONAL PRODUCT MISUSE 1358 0.0155
263 HEPATIC CYTOLYSIS 197 0.0154
264 HYPERPYREXIA 65 0.0153
265 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 157 0.0153
266 BRUXISM 82 0.0152
267 THINKING ABNORMAL 283 0.0152
268 CONGESTIVE CARDIOMYOPATHY 63 0.0151
269 MYOCARDITIS 173 0.0151
270 CIRCULATORY COLLAPSE 257 0.0151
271 OVERDOSE 3221 0.0149
272 SCOLIOSIS 92 0.0148
273 VENTRICULAR SEPTAL DEFECT 85 0.0148
274 ATELECTASIS 143 0.0148
275 CHOLELITHIASIS 484 0.0147
276 DRUG TOLERANCE 74 0.0146
277 EPILEPSY 447 0.0146
278 DYSPHEMIA 63 0.0144
279 INTESTINAL ISCHAEMIA 79 0.0143
280 HALLUCINATION, VISUAL 302 0.0143
281 EXTRAPYRAMIDAL DISORDER 355 0.0143
282 FOETAL DEATH 74 0.0143
283 ATRIAL SEPTAL DEFECT 119 0.0142
284 HEPATOTOXICITY 316 0.0142
285 APATHY 207 0.0142
286 EYE MOVEMENT DISORDER 97 0.0142
287 HYPOKINESIA 202 0.0139
288 ANGER 468 0.0138
289 SENSORY DISTURBANCE 222 0.0138
290 INGUINAL HERNIA 84 0.0138
291 ORTHOSTATIC HYPOTENSION 240 0.0138
292 ELECTROCARDIOGRAM ABNORMAL 108 0.0138
293 CONFUSIONAL STATE 2223 0.0137
294 MOOD SWINGS 431 0.0135
295 TACHYPNOEA 183 0.0134
296 OBESITY 214 0.0134
297 EUPHORIC MOOD 137 0.0134
298 DRUG WITHDRAWAL SYNDROME 1173 0.0134
299 SLEEP APNOEA SYNDROME 255 0.0133
300 MOTOR DYSFUNCTION 136 0.0133
301 HYPERLIPIDAEMIA 159 0.0133
302 BRADYCARDIA 704 0.0133
303 PAROSMIA 100 0.0132
304 PREMATURE DELIVERY 211 0.0132
305 TRICUSPID VALVE INCOMPETENCE 105 0.0132
306 OLIGURIA 82 0.0132
307 REFUSAL OF TREATMENT BY PATIENT 86 0.0132
308 HEPATOMEGALY 129 0.0131
309 KLEBSIELLA INFECTION 66 0.0130
310 COGNITIVE DISORDER 608 0.0130
311 PARALYSIS 186 0.0130
312 INTERVERTEBRAL DISC DEGENERATION 120 0.0130
313 ECONOMIC PROBLEM 196 0.0129
314 HYPERAESTHESIA 106 0.0129
315 DYSGRAPHIA 85 0.0129
316 SCREAMING 82 0.0129
317 URINARY INCONTINENCE 381 0.0128
318 MENTAL DISORDER 554 0.0127
319 POOR QUALITY SLEEP 274 0.0127
320 LOSS OF CONSCIOUSNESS 1626 0.0127
321 VITAMIN D DEFICIENCY 123 0.0126
322 BLEPHAROSPASM 79 0.0125
323 AMNESIA 816 0.0125
324 IMPAIRED DRIVING ABILITY 141 0.0124
325 DYSLIPIDAEMIA 63 0.0124
326 BLOOD POTASSIUM INCREASED 201 0.0124
327 HALLUCINATION 932 0.0124
328 OBSESSIVE-COMPULSIVE DISORDER 99 0.0123
329 RENAL INJURY 366 0.0123
330 DIABETIC NEUROPATHY 61 0.0123
331 AFFECT LABILITY 118 0.0122
332 APHASIA 368 0.0122
333 SLEEP DISORDER 858 0.0121
334 BLOOD LACTIC ACID INCREASED 64 0.0121
335 DEPRESSED MOOD 642 0.0121
336 CARDIOMYOPATHY 179 0.0121
337 ATRIOVENTRICULAR BLOCK COMPLETE 81 0.0121
338 PREMATURE BABY 364 0.0121
339 AFFECTIVE DISORDER 95 0.0121
340 SPEECH DISORDER 631 0.0120
341 CARDIOGENIC SHOCK 172 0.0120
342 DRUG WITHDRAWAL SYNDROME NEONATAL 177 0.0119
343 MUSCLE TWITCHING 275 0.0119
344 HYPOXIA 420 0.0119
345 MENTAL STATUS CHANGES 331 0.0119
346 ANXIETY 3387 0.0119
347 TREMOR 1974 0.0119
348 CARDIOTOXICITY 106 0.0119
349 RENAL TUBULAR NECROSIS 116 0.0118
350 MAJOR DEPRESSION 86 0.0118
351 IRRITABILITY 702 0.0117
352 HYPERHIDROSIS 1497 0.0116
353 ACCIDENT 137 0.0115
354 LETHARGY 659 0.0114
355 ACUTE KIDNEY INJURY 1749 0.0114
356 HYPOTENSION 2291 0.0114
357 BIPOLAR DISORDER 124 0.0114
358 HEAD INJURY 360 0.0114
359 BALANCE DISORDER 978 0.0113
360 SWOLLEN TONGUE 353 0.0113
361 HEART RATE ABNORMAL 63 0.0113
362 ABNORMAL LOSS OF WEIGHT 77 0.0113
363 VENTRICULAR TACHYCARDIA 186 0.0113
364 NEUTROPHILIA 64 0.0112
365 HEPATOCELLULAR INJURY 159 0.0112
366 PRODUCT ADMINISTRATION INTERRUPTED 88 0.0112
367 RENAL CYST 89 0.0112
368 EMPHYSEMA 113 0.0112
369 DRUG DEPENDENCE 1798 0.0112
370 OSTEOPENIA 169 0.0111
371 MULTIPLE INJURIES 70 0.0111
372 MENSTRUAL DISORDER 92 0.0111
373 EMOTIONAL DISORDER 340 0.0110
374 MUSCLE TIGHTNESS 178 0.0110
375 BLADDER DISORDER 109 0.0110
376 DEPRESSION 2451 0.0108
377 ACUTE RESPIRATORY DISTRESS SYNDROME 190 0.0107
378 NEURALGIA 260 0.0107
379 BLOOD SODIUM DECREASED 201 0.0107
380 MOVEMENT DISORDER 342 0.0106
381 METABOLIC ACIDOSIS 340 0.0106
382 CONVULSION 606 0.0106
383 RESPIRATION ABNORMAL 73 0.0106
384 FEAR 284 0.0105
385 SUPRAVENTRICULAR TACHYCARDIA 100 0.0104
386 LOW BIRTH WEIGHT BABY 83 0.0104
387 BEDRIDDEN 136 0.0103
388 POLYURIA 84 0.0102
389 BLOOD BILIRUBIN INCREASED 277 0.0102
390 ANAL INCONTINENCE 92 0.0102
391 CONCUSSION 79 0.0102
392 RESPIRATORY FAILURE 738 0.0101
393 RENAL FAILURE 1343 0.0101
394 BLOOD MAGNESIUM DECREASED 87 0.0101
395 MUSCLE STRAIN 87 0.0100
396 HYPERPROLACTINAEMIA 65 0.0100
397 VENTRICULAR EXTRASYSTOLES 104 0.0100
398 LEUKOCYTOSIS 181 0.0100
399 TREATMENT NONCOMPLIANCE 545 0.0100
400 ACUTE HEPATIC FAILURE 136 0.0099
401 WHITE BLOOD CELL COUNT INCREASED 381 0.0099
402 GAMMA-GLUTAMYLTRANSFERASE INCREASED 220 0.0099
403 MATERNAL DRUGS AFFECTING FOETUS 76 0.0099
404 HYPERSOMNIA 284 0.0099
405 THERMAL BURN 70 0.0099
406 IMPAIRED GASTRIC EMPTYING 134 0.0098
407 EATING DISORDER 209 0.0098
408 SENSATION OF FOREIGN BODY 82 0.0097
409 HYPONATRAEMIA 548 0.0097
410 RESPIRATORY DISTRESS 267 0.0097
411 ABNORMAL DREAMS 267 0.0097
412 NEUTROPENIC SEPSIS 69 0.0097
413 BLOOD LACTATE DEHYDROGENASE INCREASED 153 0.0096
414 OXYGEN SATURATION DECREASED 542 0.0096
415 MITRAL VALVE INCOMPETENCE 109 0.0096
416 URINE OUTPUT DECREASED 84 0.0096
417 DENTAL CARIES 106 0.0096
418 DECUBITUS ULCER 78 0.0096
419 CAESAREAN SECTION 111 0.0095
420 ROAD TRAFFIC ACCIDENT 396 0.0095
421 CRYING 344 0.0095
422 FEELING JITTERY 178 0.0093
423 PALLOR 254 0.0093
424 TINNITUS 427 0.0093
425 HYPOAESTHESIA ORAL 140 0.0093
426 INSOMNIA 2469 0.0093
427 TARDIVE DYSKINESIA 261 0.0092
428 ANHEDONIA 243 0.0092
429 INTERVERTEBRAL DISC PROTRUSION 202 0.0092
430 RESPIRATORY RATE INCREASED 82 0.0092
431 MYOCARDIAL ISCHAEMIA 105 0.0092
432 FULL BLOOD COUNT ABNORMAL 97 0.0092
433 FIBROMYALGIA 222 0.0091
434 LYMPHOCYTE COUNT DECREASED 161 0.0091
435 FACIAL PAIN 81 0.0091
436 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 473 0.0091
437 SPINAL PAIN 106 0.0090
438 ACUTE RESPIRATORY FAILURE 174 0.0090
439 COLITIS ISCHAEMIC 61 0.0090
440 CHOKING 176 0.0090
441 NERVE INJURY 100 0.0090
442 RESPIRATORY TRACT INFECTION 234 0.0090
443 TUBULOINTERSTITIAL NEPHRITIS 168 0.0090
444 HYPOKALAEMIA 413 0.0089
445 HEPATITIS C 108 0.0089
446 CANDIDA INFECTION 151 0.0089
447 MEMORY IMPAIRMENT 1225 0.0089
448 SPLENOMEGALY 104 0.0089
449 SKIN LACERATION 96 0.0088
450 NEPHROPATHY 82 0.0088
451 IRON DEFICIENCY ANAEMIA 81 0.0088
452 STEVENS-JOHNSON SYNDROME 195 0.0088
453 HIATUS HERNIA 113 0.0087
454 SLUGGISHNESS 89 0.0087
455 BLOOD UREA INCREASED 145 0.0087
456 CHOLECYSTITIS 103 0.0086
457 FOETAL EXPOSURE DURING PREGNANCY 701 0.0086
458 LACERATION 81 0.0086
459 INCREASED APPETITE 164 0.0086
460 NERVE COMPRESSION 79 0.0086
461 CHOLESTASIS 164 0.0085
462 FALL 2839 0.0085
463 JOINT DISLOCATION 90 0.0085
464 INITIAL INSOMNIA 87 0.0085
465 HYPERKALAEMIA 296 0.0084
466 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 217 0.0084
467 ROTATOR CUFF SYNDROME 108 0.0084
468 LIGAMENT SPRAIN 83 0.0084
469 RESPIRATORY DISORDER 251 0.0084
470 MUSCLE ATROPHY 106 0.0084
471 CARPAL TUNNEL SYNDROME 117 0.0083
472 ELECTROLYTE IMBALANCE 97 0.0083
473 ORAL DISCOMFORT 116 0.0083
474 LIVER FUNCTION TEST ABNORMAL 242 0.0083
475 NOCTURIA 101 0.0083
476 NECK PAIN 463 0.0083
477 EOSINOPHILIA 145 0.0083
478 PRESCRIBED OVERDOSE 160 0.0083
479 UROSEPSIS 76 0.0082
480 DIPLOPIA 213 0.0082
481 HEMIPARESIS 138 0.0081
482 PHOTOPHOBIA 153 0.0081
483 LOSS OF LIBIDO 73 0.0081
484 COLD SWEAT 143 0.0081
485 VENTRICULAR FIBRILLATION 90 0.0081
486 MOOD ALTERED 221 0.0081
487 MASS 113 0.0081
488 BLOOD ALBUMIN DECREASED 64 0.0081
489 OSTEOARTHRITIS 341 0.0080
490 HICCUPS 66 0.0080
491 MOUTH ULCERATION 169 0.0080
492 GAIT DISTURBANCE 1529 0.0080
493 HYPOGLYCAEMIA 387 0.0080
494 RIB FRACTURE 164 0.0080
495 PELVIC FRACTURE 62 0.0080
496 TEMPERATURE INTOLERANCE 82 0.0079
497 GASTRITIS 209 0.0079
498 MULTIPLE ORGAN DYSFUNCTION SYNDROME 224 0.0079
499 ERECTILE DYSFUNCTION 203 0.0079
500 PNEUMONIA 2547 0.0079
501 ARRHYTHMIA 372 0.0078
502 SEXUAL DYSFUNCTION 92 0.0078
503 VERTIGO 477 0.0078
504 CONSTIPATION 1704 0.0078
505 IRRITABLE BOWEL SYNDROME 167 0.0078
506 HEART RATE INCREASED 770 0.0078
507 PARAESTHESIA 1222 0.0078
508 DRY MOUTH 630 0.0078
509 FEELING COLD 216 0.0078
510 DYSPHAGIA 736 0.0077
511 NERVOUSNESS 405 0.0077
512 AGRANULOCYTOSIS 144 0.0077
513 ACTIVITIES OF DAILY LIVING IMPAIRED 153 0.0077
514 SCAR 132 0.0077
515 OESOPHAGITIS 84 0.0077
516 PULMONARY HYPERTENSION 160 0.0077
517 GASTROOESOPHAGEAL REFLUX DISEASE 617 0.0077
518 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 73 0.0076
519 MICTURITION URGENCY 87 0.0076
520 PALPITATIONS 890 0.0076
521 BLOOD URINE PRESENT 144 0.0076
522 LIMB INJURY 206 0.0076
523 EAR PAIN 147 0.0076
524 QUALITY OF LIFE DECREASED 101 0.0075
525 DIZZINESS POSTURAL 73 0.0075
526 GROIN PAIN 66 0.0075
527 ALANINE AMINOTRANSFERASE INCREASED 459 0.0075
528 HAEMATEMESIS 189 0.0074
529 ANOREXIA 96 0.0074
530 C-REACTIVE PROTEIN INCREASED 271 0.0074
531 FEEDING DISORDER 151 0.0074
532 ABNORMAL FAECES 61 0.0074
533 MUSCLE SPASMS 1362 0.0074
534 SHOCK 170 0.0074
535 TOOTHACHE 133 0.0073
536 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 402 0.0073
537 PHARYNGEAL SWELLING 71 0.0072
538 HYPERTHYROIDISM 105 0.0072
539 ABASIA 179 0.0072
540 HYPOPHAGIA 185 0.0072
541 DECREASED ACTIVITY 78 0.0072
542 SPINAL DISORDER 68 0.0072
543 ORAL CANDIDIASIS 94 0.0071
544 NO THERAPEUTIC RESPONSE 87 0.0071
545 PLATELET COUNT INCREASED 93 0.0071
546 BLOOD TRIGLYCERIDES INCREASED 126 0.0071
547 SYNCOPE 713 0.0071
548 FOOT FRACTURE 135 0.0071
549 BLOOD ALKALINE PHOSPHATASE INCREASED 176 0.0071
550 PHOTOSENSITIVITY REACTION 117 0.0071
551 LYMPHADENOPATHY 250 0.0071
552 HEAD DISCOMFORT 125 0.0071
553 MUSCULOSKELETAL CHEST PAIN 109 0.0070
554 LOWER RESPIRATORY TRACT INFECTION 320 0.0070
555 TENDERNESS 73 0.0070
556 MALNUTRITION 78 0.0070
557 THIRST 124 0.0069
558 MOBILITY DECREASED 498 0.0069
559 DYSURIA 255 0.0069
560 PULMONARY EMBOLISM 658 0.0069
561 HYPOTHYROIDISM 221 0.0069
562 URINARY TRACT INFECTION 1180 0.0069
563 BACK DISORDER 112 0.0069
564 TRANSIENT ISCHAEMIC ATTACK 232 0.0069
565 HEPATIC FUNCTION ABNORMAL 256 0.0069
566 INJURY 482 0.0069
567 MUSCULOSKELETAL STIFFNESS 600 0.0068
568 VISION BLURRED 940 0.0068
569 HYPERCHOLESTEROLAEMIA 66 0.0068
570 CONDITION AGGRAVATED 2072 0.0068
571 BODY TEMPERATURE INCREASED 139 0.0068
572 HYPERTENSION 1443 0.0068
573 BONE DISORDER 124 0.0068
574 POLLAKIURIA 283 0.0068
575 COAGULOPATHY 113 0.0068
576 OCULAR DISCOMFORT 76 0.0068
577 MATERNAL EXPOSURE DURING PREGNANCY 603 0.0068
578 BURSITIS 82 0.0068
579 OSTEOPOROSIS 278 0.0068
580 LIP SWELLING 225 0.0067
581 HYPOMAGNESAEMIA 94 0.0067
582 CONJUNCTIVITIS 125 0.0067
583 BLOOD CHOLESTEROL INCREASED 314 0.0067
584 MULTI-ORGAN FAILURE 116 0.0067
585 MUSCULAR WEAKNESS 762 0.0067
586 NERVOUS SYSTEM DISORDER 209 0.0067
587 CENTRAL NERVOUS SYSTEM LESION 92 0.0067
588 MULTIPLE SCLEROSIS RELAPSE 458 0.0067
589 WRIST FRACTURE 80 0.0067
590 HYPERTENSIVE CRISIS 74 0.0066
591 HYPOAESTHESIA 995 0.0066
592 HEPATIC FAILURE 200 0.0066
593 DIABETES MELLITUS INADEQUATE CONTROL 117 0.0066
594 VOMITING 3104 0.0066
595 ANKLE FRACTURE 102 0.0066
596 SMALL INTESTINAL OBSTRUCTION 81 0.0066
597 HYPERCALCAEMIA 81 0.0066
598 SWELLING FACE 426 0.0065
599 MEDICATION ERROR 363 0.0065
600 PHARYNGITIS 81 0.0065
601 DISABILITY 129 0.0065
602 MIGRAINE 621 0.0065
603 CHEST PAIN 1204 0.0065
604 PNEUMOTHORAX 103 0.0065
605 SPINAL OPERATION 80 0.0065
606 TYPE 2 DIABETES MELLITUS 218 0.0065
607 GASTRIC ULCER 123 0.0065
608 EYE INFECTION 73 0.0065
609 BLOOD PRESSURE DECREASED 429 0.0065
610 GINGIVAL BLEEDING 88 0.0064
611 BLOOD POTASSIUM DECREASED 193 0.0064
612 RED BLOOD CELL SEDIMENTATION RATE INCREASED 71 0.0064
613 IMPAIRED QUALITY OF LIFE 92 0.0064
614 DRUG LEVEL DECREASED 65 0.0064
615 GASTROENTERITIS 93 0.0064
616 CONTUSION 612 0.0064
617 DIABETES MELLITUS 484 0.0063
618 CYSTITIS 202 0.0063
619 HAEMATOMA 164 0.0063
620 BACK PAIN 1470 0.0063
621 OEDEMA PERIPHERAL 770 0.0063
622 SEPTIC SHOCK 274 0.0063
623 FEELING ABNORMAL 1506 0.0063
624 ILEUS 78 0.0063
625 WEIGHT INCREASED 1401 0.0062
626 MULTIPLE SCLEROSIS 299 0.0062
627 VISUAL ACUITY REDUCED 207 0.0062
628 IMPAIRED WORK ABILITY 133 0.0062
629 DRUG EXPOSURE DURING PREGNANCY 211 0.0062
630 BLISTER 347 0.0062
631 EJECTION FRACTION DECREASED 96 0.0062
632 BODY HEIGHT DECREASED 66 0.0062
633 HAEMOPTYSIS 172 0.0062
634 DYSSTASIA 179 0.0061
635 FRACTURE 116 0.0061
636 DECREASED APPETITE 1420 0.0061
637 NIGHT SWEATS 196 0.0061
638 DIZZINESS 3028 0.0061
639 DEHYDRATION 807 0.0060
640 DRUG RESISTANCE 155 0.0060
641 TRANSAMINASES INCREASED 134 0.0060
642 GLOMERULAR FILTRATION RATE DECREASED 74 0.0060
643 BLOOD CREATININE INCREASED 392 0.0060
644 WHEEZING 356 0.0060
645 SECRETION DISCHARGE 75 0.0060
646 HYPOCALCAEMIA 113 0.0060
647 BRONCHOSPASM 85 0.0060
648 BRAIN FOG 93 0.0059
649 CORONARY ARTERY OCCLUSION 81 0.0059
650 HEPATIC ENZYME INCREASED 402 0.0059
651 TOOTH DISORDER 131 0.0059
652 SKIN INFECTION 66 0.0059
653 LIMB DISCOMFORT 182 0.0059
654 POST PROCEDURAL COMPLICATION 112 0.0058
655 EYE PAIN 329 0.0058
656 PANCREATITIS ACUTE 131 0.0058
657 PERIPHERAL COLDNESS 80 0.0058
658 PYREXIA 2016 0.0058
659 MUSCULOSKELETAL PAIN 302 0.0058
660 WEIGHT DECREASED 1600 0.0057
661 ABDOMINAL DISTENSION 597 0.0057
662 DEVICE RELATED INFECTION 88 0.0057
663 TOOTH FRACTURE 63 0.0057
664 MALAISE 2505 0.0057
665 HEART RATE IRREGULAR 129 0.0057
666 BACK INJURY 62 0.0057
667 HAEMATOCRIT DECREASED 113 0.0057
668 THROAT TIGHTNESS 154 0.0057
669 ANGINA PECTORIS 163 0.0057
670 PARAESTHESIA ORAL 82 0.0057
671 REBOUND EFFECT 64 0.0057
672 SKIN DISCOLOURATION 260 0.0057
673 SCIATICA 90 0.0056
674 EAR INFECTION 150 0.0056
675 INTESTINAL OBSTRUCTION 212 0.0056
676 MIDDLE INSOMNIA 105 0.0056
677 DEEP VEIN THROMBOSIS 364 0.0056
678 RENAL IMPAIRMENT 470 0.0056
679 HEART RATE DECREASED 196 0.0056
680 JAUNDICE 150 0.0056
681 PRESCRIBED UNDERDOSE 111 0.0056
682 LOCAL SWELLING 97 0.0056
683 ASTHENIA 2089 0.0056
684 HYPERGLYCAEMIA 202 0.0055
685 RASH MACULO-PAPULAR 123 0.0055
686 DYSPHONIA 323 0.0055
687 VISUAL IMPAIRMENT 684 0.0055
688 STAPHYLOCOCCAL INFECTION 182 0.0055
689 MYALGIA 938 0.0055
690 APHONIA 77 0.0055
691 SKIN LESION 151 0.0055
692 FOOT DEFORMITY 61 0.0055
693 VASCULITIS 64 0.0055
694 HEPATIC CIRRHOSIS 103 0.0055
695 NEUROTOXICITY 96 0.0055
696 SEPSIS 610 0.0055
697 TOOTH INFECTION 72 0.0055
698 DYSPNOEA 3080 0.0054
699 PAIN IN JAW 154 0.0054
700 NEPHROLITHIASIS 249 0.0054
701 JOINT STIFFNESS 142 0.0054
702 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 260 0.0054
703 FEELING HOT 330 0.0054
704 HAEMORRHOIDS 105 0.0054
705 VIRAL INFECTION 179 0.0054
706 GASTROENTERITIS VIRAL 97 0.0054
707 THERAPY NON-RESPONDER 241 0.0054
708 LOWER LIMB FRACTURE 103 0.0054
709 TENDONITIS 83 0.0054
710 CELLULITIS 268 0.0053
711 NAUSEA 4204 0.0053
712 PAIN IN EXTREMITY 1555 0.0053
713 PAIN 3237 0.0053
714 PHARYNGEAL OEDEMA 81 0.0053
715 BRONCHITIS 389 0.0053
716 THYROID DISORDER 81 0.0052
717 ASPARTATE AMINOTRANSFERASE INCREASED 279 0.0052
718 CORONARY ARTERY DISEASE 159 0.0052
719 GENERAL PHYSICAL HEALTH DETERIORATION 606 0.0052
720 MUSCULOSKELETAL DISCOMFORT 90 0.0052
721 HEADACHE 3270 0.0052
722 RENAL FAILURE ACUTE 221 0.0052
723 INFUSION SITE PAIN 67 0.0052
724 DYSPEPSIA 510 0.0052
725 CHROMATURIA 116 0.0051
726 EMOTIONAL DISTRESS 622 0.0051
727 UPPER LIMB FRACTURE 102 0.0051
728 POLYNEUROPATHY 61 0.0051
729 CYST 63 0.0051
730 UPPER RESPIRATORY TRACT INFECTION 233 0.0050
731 BLOOD PRESSURE FLUCTUATION 121 0.0050
732 PRURITUS GENERALISED 109 0.0050
733 THERAPEUTIC RESPONSE UNEXPECTED 226 0.0050
734 EXPOSURE DURING PREGNANCY 313 0.0050
735 BURNING SENSATION 353 0.0050
736 GASTRIC DISORDER 172 0.0050
737 GENERALISED OEDEMA 62 0.0050
738 PANCREATITIS 263 0.0050
739 ABSCESS 79 0.0049
740 UPPER GASTROINTESTINAL HAEMORRHAGE 83 0.0049
741 INFLUENZA LIKE ILLNESS 406 0.0049
742 BONE PAIN 287 0.0049
743 BLOOD PRESSURE INCREASED 749 0.0049
744 WHITE BLOOD CELL COUNT DECREASED 531 0.0049
745 FATIGUE 3807 0.0049
746 PERICARDIAL EFFUSION 113 0.0049
747 DEMENTIA 136 0.0049
748 WOUND 136 0.0049
749 BLINDNESS 198 0.0049
750 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 83 0.0048
751 DRUG PRESCRIBING ERROR 93 0.0048
752 LUNG DISORDER 237 0.0048
753 BLOOD COUNT ABNORMAL 73 0.0048
754 LIVER INJURY 118 0.0048
755 CHEST DISCOMFORT 492 0.0048
756 SPINAL FRACTURE 96 0.0048
757 NEUTROPHIL COUNT DECREASED 195 0.0048
758 GLAUCOMA 92 0.0048
759 ABDOMINAL PAIN UPPER 982 0.0048
760 BLOOD TEST ABNORMAL 67 0.0048
761 DISSEMINATED INTRAVASCULAR COAGULATION 67 0.0048
762 HOT FLUSH 358 0.0047
763 DRUG ERUPTION 84 0.0047
764 BONE DENSITY DECREASED 148 0.0047
765 RED BLOOD CELL COUNT DECREASED 135 0.0047
766 LOCALISED INFECTION 114 0.0047
767 OSTEOMYELITIS 85 0.0047
768 KIDNEY INFECTION 92 0.0047
769 ABDOMINAL PAIN 1086 0.0047
770 NEUROPATHY PERIPHERAL 444 0.0047
771 INTENTIONAL PRODUCT USE ISSUE 407 0.0046
772 RASH MACULAR 162 0.0046
773 OEDEMA 251 0.0046
774 BACTERIAL INFECTION 86 0.0046
775 WRONG TECHNIQUE IN DRUG USAGE PROCESS 167 0.0046
776 GAIT INABILITY 153 0.0046
777 CHILLS 536 0.0046
778 AMENORRHOEA 80 0.0046
779 RECTAL HAEMORRHAGE 196 0.0046
780 FLUSHING 458 0.0045
781 PRODUCT TASTE ABNORMAL 61 0.0045
782 SINUS DISORDER 89 0.0045
783 LACTIC ACIDOSIS 145 0.0045
784 BLOOD PRESSURE ABNORMAL 89 0.0045
785 UNEVALUABLE EVENT 338 0.0045
786 PLEURAL EFFUSION 271 0.0044
787 LUNG NEOPLASM MALIGNANT 182 0.0044
788 FLATULENCE 251 0.0044
789 FEMUR FRACTURE 137 0.0044
790 LEUKOPENIA 221 0.0044
791 PRODUCT ADMINISTRATION ERROR 89 0.0044
792 PERIPHERAL SWELLING 678 0.0044
793 JOINT INJURY 94 0.0044
794 MULTIPLE FRACTURES 72 0.0044
795 DIVERTICULITIS 121 0.0044
796 CONTRAINDICATED PRODUCT ADMINISTERED 131 0.0043
797 SKIN DISORDER 144 0.0043
798 LIVER DISORDER 191 0.0043
799 ACUTE MYOCARDIAL INFARCTION 127 0.0043
800 HEPATITIS 110 0.0043
801 CARDIAC FAILURE 345 0.0043
802 THERAPY CESSATION 220 0.0043
803 CARDIAC DISORDER 399 0.0043
804 SURGERY 250 0.0043
805 CEREBRAL INFARCTION 104 0.0043
806 DIABETIC KETOACIDOSIS 102 0.0042
807 DIARRHOEA 2725 0.0042
808 RETCHING 90 0.0042
809 INFLUENZA 470 0.0042
810 FACE OEDEMA 71 0.0042
811 ATRIAL FIBRILLATION 410 0.0042
812 HAEMATURIA 144 0.0042
813 PERITONITIS 87 0.0042
814 COUGH 1171 0.0042
815 PRODUCT SUBSTITUTION ISSUE 239 0.0041
816 TOOTH LOSS 86 0.0041
817 HIP FRACTURE 133 0.0041
818 ARTHRALGIA 1717 0.0041
819 SINUSITIS 421 0.0041
820 ABDOMINAL DISCOMFORT 688 0.0041
821 NEUTROPENIA 555 0.0041
822 ARTHRITIS 321 0.0041
823 HAEMOGLOBIN DECREASED 418 0.0041
824 ORAL PAIN 91 0.0041
825 OFF LABEL USE 3550 0.0041
826 OROPHARYNGEAL PAIN 375 0.0040
827 MELAENA 89 0.0040
828 PRODUCTIVE COUGH 192 0.0040
829 PRODUCT USE IN UNAPPROVED INDICATION 995 0.0040
830 SWELLING 374 0.0040
831 EYE DISORDER 131 0.0040
832 EPISTAXIS 298 0.0040
833 FAECES DISCOLOURED 86 0.0040
834 CATARACT 236 0.0040
835 IMPAIRED HEALING 130 0.0040
836 RENAL DISORDER 184 0.0039
837 PRESYNCOPE 96 0.0039
838 DEATH 3387 0.0039
839 HERNIA 76 0.0039
840 FUNGAL INFECTION 131 0.0039
841 HYPOACUSIS 169 0.0039
842 MYOCARDIAL INFARCTION 684 0.0039
843 ANAEMIA 746 0.0039
844 GOUT 70 0.0039
845 RASH GENERALISED 101 0.0039
846 ILL-DEFINED DISORDER 236 0.0039
847 ECZEMA 203 0.0039
848 PERICARDITIS 65 0.0039
849 ANAPHYLACTIC REACTION 212 0.0038
850 DRUG INEFFECTIVE 5045 0.0038
851 RASH ERYTHEMATOUS 182 0.0038
852 ARTHROPATHY 211 0.0038
853 MUSCULOSKELETAL DISORDER 72 0.0038
854 ALOPECIA 741 0.0038
855 DRUG INTOLERANCE 364 0.0038
856 DRY EYE 188 0.0038
857 GALLBLADDER DISORDER 67 0.0037
858 PELVIC PAIN 68 0.0037
859 DEAFNESS 97 0.0037
860 EYE SWELLING 138 0.0037
861 DRUG-INDUCED LIVER INJURY 116 0.0037
862 DRUG EFFECT DECREASED 199 0.0037
863 HERPES ZOSTER 212 0.0037
864 INTERNATIONAL NORMALISED RATIO INCREASED 105 0.0037
865 RHINORRHOEA 238 0.0037
866 ILLNESS 379 0.0037
867 GASTROINTESTINAL DISORDER 329 0.0037
868 PRODUCT PHYSICAL ISSUE 74 0.0037
869 INFECTION 529 0.0037
870 JOINT SWELLING 441 0.0036
871 BLOOD PRESSURE SYSTOLIC INCREASED 71 0.0036
872 THROMBOCYTOPENIA 407 0.0036
873 DYSPNOEA EXERTIONAL 137 0.0036
874 PRODUCT USE ISSUE 683 0.0036
875 DISEASE RECURRENCE 172 0.0036
876 ANAPHYLACTIC SHOCK 93 0.0036
877 PROCEDURAL PAIN 100 0.0036
878 SKIN ULCER 93 0.0036
879 ASTHMA 406 0.0036
880 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 255 0.0036
881 PROTEINURIA 68 0.0036
882 GLOSSODYNIA 80 0.0036
883 ADVERSE DRUG REACTION 320 0.0036
884 THERAPEUTIC RESPONSE DECREASED 215 0.0035
885 INFLAMMATION 183 0.0035
886 PRODUCT PRESCRIBING ISSUE 77 0.0035
887 PNEUMONITIS 96 0.0035
888 DYSGEUSIA 260 0.0035
889 PRODUCT PRESCRIBING ERROR 83 0.0035
890 CARDIOVASCULAR DISORDER 88 0.0035
891 PHARMACEUTICAL PRODUCT COMPLAINT 90 0.0035
892 THROMBOSIS 278 0.0035
893 PANCYTOPENIA 193 0.0034
894 DISCOMFORT 210 0.0034
895 ANGIOEDEMA 151 0.0034
896 THROAT IRRITATION 151 0.0034
897 CARDIAC FAILURE CONGESTIVE 270 0.0034
898 CLOSTRIDIUM DIFFICILE INFECTION 73 0.0033
899 HAEMATOCHEZIA 184 0.0033
900 ORAL HERPES 65 0.0033
901 HYPERSENSITIVITY 618 0.0033
902 DRUG ADMINISTRATION ERROR 102 0.0033
903 LACRIMATION INCREASED 100 0.0033
904 ASCITES 97 0.0033
905 RASH 1438 0.0033
906 PREGNANCY 66 0.0033
907 CEREBRAL HAEMORRHAGE 117 0.0033
908 STOMATITIS 198 0.0033
909 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 232 0.0033
910 LABORATORY TEST ABNORMAL 96 0.0032
911 HAEMORRHAGE 340 0.0032
912 DEVICE USE ERROR 113 0.0032
913 NASAL CONGESTION 191 0.0032
914 PSORIATIC ARTHROPATHY 131 0.0032
915 GASTROINTESTINAL HAEMORRHAGE 269 0.0032
916 PLATELET COUNT DECREASED 341 0.0032
917 PRURITUS 1229 0.0032
918 COLITIS 120 0.0032
919 RASH PRURITIC 171 0.0032
920 DERMATITIS 66 0.0031
921 KNEE ARTHROPLASTY 66 0.0031
922 RASH PAPULAR 70 0.0031
923 PRODUCT AVAILABILITY ISSUE 71 0.0031
924 OSTEONECROSIS 102 0.0031
925 ERYTHEMA 637 0.0031
926 CEREBROVASCULAR ACCIDENT 524 0.0031
927 NASOPHARYNGITIS 569 0.0031
928 INTENTIONAL DOSE OMISSION 87 0.0030
929 DEPENDENCE 166 0.0030
930 DEVICE MALFUNCTION 210 0.0030
931 LIVER FUNCTION TEST INCREASED 64 0.0030
932 HOSPITALISATION 458 0.0030
933 INCORRECT ROUTE OF DRUG ADMINISTRATION 106 0.0030
934 FLUID RETENTION 149 0.0029
935 PRODUCT DOSE OMISSION 190 0.0029
936 SKIN EXFOLIATION 242 0.0029
937 DRUG DOSE OMISSION 467 0.0028
938 GLYCOSYLATED HAEMOGLOBIN INCREASED 71 0.0028
939 DRUG EFFECT INCOMPLETE 101 0.0028
940 UNDERDOSE 202 0.0028
941 SYSTEMIC LUPUS ERYTHEMATOSUS 97 0.0027
942 PRODUCT DOSE OMISSION IN ERROR 77 0.0027
943 OSTEONECROSIS OF JAW 65 0.0026
944 OCULAR HYPERAEMIA 123 0.0026
945 BLOOD GLUCOSE INCREASED 486 0.0026
946 URTICARIA 431 0.0026
947 ABDOMINAL PAIN LOWER 64 0.0025
948 COVID-19 440 0.0025
949 PRODUCT QUALITY ISSUE 336 0.0025
950 TREATMENT FAILURE 204 0.0025
951 VAGINAL HAEMORRHAGE 104 0.0024
952 INCORRECT DRUG ADMINISTRATION DURATION 67 0.0024
953 PSORIASIS 308 0.0024
954 INFUSION RELATED REACTION 155 0.0023
955 DISEASE PROGRESSION 273 0.0023
956 THERAPEUTIC RESPONSE SHORTENED 76 0.0023
957 EYE IRRITATION 128 0.0022
958 PRODUCT ADHESION ISSUE 79 0.0022
959 BLOOD GLUCOSE DECREASED 106 0.0022
960 PRODUCT DOSE OMISSION ISSUE 645 0.0022
961 THERAPY INTERRUPTED 155 0.0022
962 FEBRILE NEUTROPENIA 142 0.0021
963 INTERSTITIAL LUNG DISEASE 102 0.0021
964 NEOPLASM MALIGNANT 140 0.0021
965 ADVERSE EVENT 190 0.0021
966 INCORRECT DOSE ADMINISTERED 466 0.0020
967 ABORTION SPONTANEOUS 78 0.0019
968 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 392 0.0019
969 INJECTION SITE MASS 71 0.0019
970 RHEUMATOID ARTHRITIS 216 0.0019
971 DRY SKIN 247 0.0018
972 EYE PRURITUS 62 0.0018
973 EXPIRED PRODUCT ADMINISTERED 61 0.0018
974 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 328 0.0018
975 NO ADVERSE EVENT 326 0.0018
976 INJECTION SITE BRUISING 132 0.0017
977 THERAPEUTIC PRODUCT EFFECT DECREASED 74 0.0017
978 SKIN BURNING SENSATION 118 0.0016
979 DEVICE DISLOCATION 70 0.0016
980 MALIGNANT NEOPLASM PROGRESSION 163 0.0016
981 PLASMA CELL MYELOMA 61 0.0016
982 INJECTION SITE REACTION 107 0.0016
983 SKIN IRRITATION 70 0.0015
984 DEVICE ISSUE 128 0.0014
985 INJECTION SITE PRURITUS 95 0.0014
986 INJECTION SITE ERYTHEMA 174 0.0014
987 BREAST CANCER 130 0.0014
988 ACNE 101 0.0013
989 DERMATITIS ATOPIC 66 0.0013
990 INJECTION SITE PAIN 375 0.0012
991 INJECTION SITE HAEMORRHAGE 90 0.0011
992 INJECTION SITE SWELLING 84 0.0011
993 ACCIDENTAL EXPOSURE TO PRODUCT 111 0.0011